NOC
54
6
FFIV
47
-3
MA
55
4
ROK
47
4
TGNA
53
-3
PM
49
2
C
82
3
XEL
37
-2
DRI
66
2
ABBV
59
13
LOW
43
-6
INTC
43
6
V
52
2
JBHT
65
2
NOV
52
4
ROP
38
-4
COP
47
3
PCAR
52
-10
CFG
95
2
GIS
58
-2
NOC
54
6
FFIV
47
-3
MA
55
4
ROK
47
4
TGNA
53
-3
PM
49
2
C
82
3
XEL
37
-2
DRI
66
2
ABBV
59
13
LOW
43
-6
INTC
43
6
V
52
2
JBHT
65
2
NOV
52
4
ROP
38
-4
COP
47
3
PCAR
52
-10
CFG
95
2
GIS
58
-2
Financhill
Back

NYLI Global Equity R&D Leaders ETF Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison

Buy
64

WRND
NYLI Global Equity R&D Leaders ETF

Last Price:
$36.82
Seasonality Move:
7.02%
Buy
54

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:
$61.19
Seasonality Move:
5.52%
Buy
64
NYLI Global Equity R&D Leaders ETF (WRND) is a Buy

Is NYLI Global Equity R&D Leaders ETF a Buy, Sell or Hold?

  • The current NYLI Global Equity R&D Leaders ETF [WRND] share price is $36.71. The Score for WRND is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • WRND is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN) is a Buy

Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

WRND Stock Price Chart

What is NYLI Global Equity R&D Leaders ETF's stock price today?

  • The NYLI Global Equity R&D Leaders ETF share price today is $36.71
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WRND is experiencing slight buying pressure.

BMRN Stock Price Chart

What is BioMarin Pharmaceutical, Inc.'s stock price today?

  • The BioMarin Pharmaceutical, Inc. share price today is $61.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.

WRND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.84 Buy
Relative Strength Index (14 RSI): 49.06 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.09 - 37.29) Buy
Bollinger Bands (100): (34.54 - 37.26) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 73.39 Buy
Chaikin Money Flow: 7836963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.19 - 56.01) Buy
Bollinger Bands (100): (52.65 - 57.43) Buy

WRND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.77 Sell
20-day SMA: 36.85 Sell
50-day SMA: 36.83 Sell
200-day SMA: 33.35 Buy
8-day EMA: 19.26 Buy
20-day EMA: 9.43 Buy
50-day EMA: 4.11 Buy
200-day EMA: 1.07 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.6 Buy
20-day SMA: 54.21 Buy
50-day SMA: 53.61 Buy
200-day SMA: 57.94 Buy
8-day EMA: 54.44 Buy
20-day EMA: 53.99 Buy
50-day EMA: 54.1 Buy
200-day EMA: 58.28 Buy

NYLI Global Equity R&D Leaders ETF Earnings Growth & WRND Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.68 per share.

NYLI Global Equity R&D Leaders ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioMarin Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):